215 related articles for article (PubMed ID: 24407358)
1. The function of FOXO1 in the late phases of the cell cycle is suppressed by PLK1-mediated phosphorylation.
Yuan C; Wang L; Zhou L; Fu Z
Cell Cycle; 2014; 13(5):807-19. PubMed ID: 24407358
[TBL] [Abstract][Full Text] [Related]
2. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer.
Gheghiani L; Shang S; Fu Z
Sci Rep; 2020 Jul; 10(1):12327. PubMed ID: 32704044
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 1-mediated phosphorylation of Forkhead box protein M1b antagonizes its SUMOylation and facilitates its mitotic function.
Zhang J; Yuan C; Wu J; Elsayed Z; Fu Z
J Biol Chem; 2015 Feb; 290(6):3708-19. PubMed ID: 25533473
[TBL] [Abstract][Full Text] [Related]
4. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression.
Fu Z; Malureanu L; Huang J; Wang W; Li H; van Deursen JM; Tindall DJ; Chen J
Nat Cell Biol; 2008 Sep; 10(9):1076-82. PubMed ID: 19160488
[TBL] [Abstract][Full Text] [Related]
5. JNK-associated Leucine Zipper Protein Functions as a Docking Platform for Polo-like Kinase 1 and Regulation of the Associating Transcription Factor Forkhead Box Protein K1.
Ramkumar P; Lee CM; Moradian A; Sweredoski MJ; Hess S; Sharrocks AD; Haines DS; Reddy EP
J Biol Chem; 2015 Dec; 290(49):29617-28. PubMed ID: 26468278
[TBL] [Abstract][Full Text] [Related]
6. FOXO1-dependent DNA damage repair is regulated by JNK in lung cancer cells.
Ju Y; Xu T; Zhang H; Yu A
Int J Oncol; 2014 Apr; 44(4):1284-92. PubMed ID: 24452601
[TBL] [Abstract][Full Text] [Related]
7. The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors.
Moore XTR; Gheghiani L; Fu Z
Cells; 2023 May; 12(9):. PubMed ID: 37174744
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.
Yen CC; Hsiao CD; Chen WM; Wen YS; Lin YC; Chang TW; Yao FY; Hung SC; Wang JY; Chiu JH; Wang HW; Lin CH; Chen TH; Chen PC; Liu CL; Tzeng CH; Fletcher JA
Oncotarget; 2014 Feb; 5(3):716-25. PubMed ID: 24566468
[TBL] [Abstract][Full Text] [Related]
9. A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1.
Raab M; Matthess Y; Raab CA; Gutfreund N; Dötsch V; Becker S; Sanhaji M; Strebhardt K
Oncogene; 2022 Jan; 41(3):372-386. PubMed ID: 34759346
[TBL] [Abstract][Full Text] [Related]
10. Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons.
Yuan Z; Becker EB; Merlo P; Yamada T; DiBacco S; Konishi Y; Schaefer EM; Bonni A
Science; 2008 Mar; 319(5870):1665-8. PubMed ID: 18356527
[TBL] [Abstract][Full Text] [Related]
11. PLK1 phosphorylates PAX3-FOXO1, the inhibition of which triggers regression of alveolar Rhabdomyosarcoma.
Thalhammer V; Lopez-Garcia LA; Herrero-Martin D; Hecker R; Laubscher D; Gierisch ME; Wachtel M; Bode P; Nanni P; Blank B; Koscielniak E; Schäfer BW
Cancer Res; 2015 Jan; 75(1):98-110. PubMed ID: 25398439
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation.
Koida N; Ozaki T; Yamamoto H; Ono S; Koda T; Ando K; Okoshi R; Kamijo T; Omura K; Nakagawara A
J Biol Chem; 2008 Mar; 283(13):8555-63. PubMed ID: 18174154
[TBL] [Abstract][Full Text] [Related]
13. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor.
Liu P; Kao TP; Huang H
Oncogene; 2008 Aug; 27(34):4733-44. PubMed ID: 18408765
[TBL] [Abstract][Full Text] [Related]
14. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
Ando K; Ozaki T; Hirota T; Nakagawara A
PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
[TBL] [Abstract][Full Text] [Related]
15. Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells.
Lee SY; Lee GR; Woo DH; Park NH; Cha HJ; Moon YH; Han IS
Cell Cycle; 2013 Jan; 12(1):67-75. PubMed ID: 23255113
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.
Bibi N; Parveen Z; Rashid S
PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120
[TBL] [Abstract][Full Text] [Related]
18. Designed inhibitor for nuclear localization signal of polo-like kinase 1 induces mitotic arrest.
Chen F; Zhuo X; Qin T; Guo X; Zhang C; Lai L
Chem Biol Drug Des; 2017 May; 89(5):732-740. PubMed ID: 27882722
[TBL] [Abstract][Full Text] [Related]
19. FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition.
Pietilä M; Vijay GV; Soundararajan R; Yu X; Symmans WF; Sphyris N; Mani SA
Sci Rep; 2016 Apr; 6():23070. PubMed ID: 27064522
[TBL] [Abstract][Full Text] [Related]
20. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression.
Kim SJ; Winter K; Nian C; Tsuneoka M; Koda Y; McIntosh CH
J Biol Chem; 2005 Jun; 280(23):22297-307. PubMed ID: 15817464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]